Human serum albumin in the clinical syndrome of heart failure

Journal of Cardiac Failure

Volumn 17, Issue 6, 2011, Pages 451-458

  Arques, Stephane ^a   Ambrosi, Pierre ^b  

^a Aubagne Hospital   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

albumin administration; nutritional intervention; Plasma oncotic pressure; prognosis

Indexed keywords

HUMAN SERUM ALBUMIN;

BIOCHEMISTRY; HEART FAILURE; HUMAN; HYDROSTATIC PRESSURE; HYPOALBUMINEMIA; LIVER DYSFUNCTION; LUNG EDEMA; OSMOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW;

HEART FAILURE; HUMANS; HYPOALBUMINEMIA; PROGNOSIS; PULMONARY EDEMA;

EID: 79957871079     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.02.010     Document Type: Review

References (96)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al., American College of Cardiology Foundation; American Heart Association. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation, American Heart Association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol 2009;53:e1-e90.
2. Lawler PR, Filion KB, Eisenberg MJ. Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents. J Card Fail 2010;16:649-58.
3. Waldum B, Westheim AS, Sandvik L, Flonaes B, Grundtvig M, Gullestad L, et al. Renal function in outpatients with chronic heart failure. J Card Fail 2010;16:374-80.
4. Kazory A, Ross EA. Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol 2009;53: 639-47.
5. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005;41:1211-9. (Pubitemid 40770271)
6. De Feo P, Horber FF, Haymond MW. Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans. Am J Physiol 1992;263(4 Pt 1):E794-9.
7. De Feo P, Volpi E, Lucidi P, Cruciani G, Reboldi G, Siepi D, et al. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic protein in normal humans. Diabetes 1993;42:995-1002. (Pubitemid 23182165)
8. Kang J, Holland M, Jones H, Kaysen GA. Coordinate augmentation in expression of genes encoding transcription factors and liver secretory proteins in hypo-oncotic states. Kidney Int 1999;56:452-60. (Pubitemid 29353142)
9. Yedgar S, Carew TE, Pittman RC, Beltz WF, Steinberg D. Tissue sites of catabolism of albumin in rabbits. Am J Physiol 1983;244:E101-7.
10. Strobel JL, Cady SG, Borg TK, Terracio L, Baynes JW, Thorpe SR. Identification of fibroblasts as a major site of albumin catabolism in peripheral tissues. J Biol Chem 1986;261:7989-94. (Pubitemid 17208733)
11. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008;582:1783-7.
12. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 2002;55:820-9.
13. Landis EM, Pappenheimer JR. Exchange of substances through the capillary walls. In: Hamilton WF, editor. Handbook of Physiology, Sec 2, Vol 2. Baltimore: Williams & Wilkins; 1963. p. 961-1034.
14. Morissette MP. Colloid osmotic pressure: its measurement and clinical value. Can Med Assoc J 1977;116:897-900. (Pubitemid 8106882)
15. Mullins RE, Pappas AA, Gadsden RH. Correlation of standardized serum protein determinations with calculated and measured colloid osmotic pressure. Am J Clin Pathol 1983;80:170-5. (Pubitemid 13032725)
16. Parker JC. Hydraulic conductance of lung endothelial phenotypes and Starling safety factors against edema. Am J Physiol Lung Cell Mol Physiol 2007;292:378-80.
17. Zarins CK, Rice CL, Peters RM, Virgilio RW. Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons. Circ Res 1978;43:925-30.
18. Hara N, Nagashima A, Yoshida T, Furukawa T, Inokuchi K. Effect of decreased plasma colloid osmotic pressure on development of pulmonary edema in dogs. Jpn J Surg 1981;11:203-8. (Pubitemid 11035727)
19. Saldias FJ, Azzam ZS, Ridge KM, Yeldandi A, Rutschman DH, Schraufnagel D, et al. Alveolar fluid reabsorption is impaired by increased left atrial pressures in rats. Am J Physiol Lung Cell Mol Physiol 2001;281:L591-7.
20. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, et al., CHARM Investigators. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009;11: 170-7.
21. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008;155:883-9.
22. Novack V, Pencina M, Zahger D, Fuchs L, Nevzorov R, Jotkowitz A, et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS ONE 2010;5:e12184.
23. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002;90:1405-9. (Pubitemid 35449493)
24. Arques S, Roux E, Sbragia P, Gelisse R, Pieri B, Ambrosi P. Usefulness of serum albumin concentration for in-hospital risk stratification in frail, elderly patients with acute heart failure. Insights from a prospective, monocenter study. Int J Cardiol 2008;125:265-7. (Pubitemid 351400232)
25. Uthamalingam S, Kandala J, Daley M, Patvardhan E, Capodilupo R, Moore SA, et al. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 2010;160:1149-55.
26. Araújo JP, Lourenço P, Rocha-Gonçalves F, Ferreira A, Bettencourt P. Nutritional markers and prognosis in cardiac cachexia. Int J Cardiol 2011;146:359-63.
27. von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia: a systematic overview. Pharmacol Ther 2009;121:227-52.
28. Chojkier M. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol 2005;39(4 Suppl. 2):S143-6.
29. Adlbrecht C, Kommata S, H€ulsmann M, Szekeres T, Bieglmayer C, Strunk G, et al. Chronic heart failure leads to an expended plasma volume and pseudoanemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008;29:2343-50.
30. Kataoka H. Short term changes in hematologic and biochemical tests during follow-up of definite heart failure patients. Int J Cardiol 2010; 144:441-4.
31. Ajayi AA, Adigun AQ, Ojofeitimi EO, Yusuph H, Ajayi OE. Anthropometric evaluation of cachexia in chronic congestive heart failure: the role of tricuspid regurgitation. Int J Cardiol 1999;71:79-84. (Pubitemid 29457784)
32. Battin DL, Ali S, Shahbaz AU, Massie JD, Munir A, Davis RC Jr, et al. Hypoalbuminemia and lymphocytopenia in patients with decompensated biventricular failure. Am J Med Sci 2010;339:31-5.
33. Parving HH, Rossing N, Nielsen SL, Lassen NA. Increased transcapillary escape rate of albumin, IgG, and IgM after plasma volume expansion. Am J Physiol 1974;227:245-50.
34. Hesse B, Parving HH, Lund-Jacobsen H, Noer I. Transcapillary escape rate of albumin and right atrial pressure in chronic congestive heart failure before and after treatment. Circ Res 1976;39:358-62.
35. Jackson CE, Salomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543-50.
36. Guyton AC, Lindsey AW. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959;7:649-57.
37. Gaar KA Jr, Taylor AE, Owens LJ, Guyton AC. Effect of capillary pressure and plasma protein on development of pulmonary edema. Am J Physiol 1967;213:79-82.
38. Levine OR, Mellins RB, Senior RM, Fishman AP. The application of Starling's law of capillary exchange to the lungs. J Clin Invest 1967; 46:934-44.
39. Drake RE, Smith JH, Gabel JC. Estimation of the filtration coefficient in the intact dog lungs. Am J Physiol 1980;238:H430-8.
40. Luz da PL, Shubin H, Weil MH, Jacobson E, Stein L. Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction. Circulation 1975;51:350-7.
41. Weil MH, Henning RJ, Morissette M, Michaels S. Relationship between colloid osmotic pressure and pulmonary artery wedge pressure in patients with acute cardiorespiratory failure. Am J Med 1978;64: 643-50. (Pubitemid 8322914)
42. Rackow EC, Fein IA, Siegel J. The relationship of the colloid osmoticpulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest 1982;82:433-7. (Pubitemid 12000601)
43. Stein L, Beraud JJ, Morissette M, Luz PD, Weil MH, Shubin H. Pulmonary edema during volume infusion. Circulation 1975;52:483-9.
44. van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009;37:1275-81.
45. EisingGP, Niemeyer M, Gunther T, Tassani P, Pfauder M, Schad H, et al. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery? Eur J Cardiothorac Surg 2001;20:282-9.
46. Arques S, Ambrosi P, Gelisse R, Luccioni R, Habib G. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003;42:712-6. (Pubitemid 37000191)
47. Arques S, Roux E, Sbragia P, Ambrosi P, Pieri B, Gelisse R, et al. Btype natriuretic peptide and tissue Doppler study findings in elderly patients hospitalized for acute diastolic heart failure. Am J Cardiol 2005;96:104-7. (Pubitemid 40853951)
48. Arques S, Ambrosi P, Roux E, Sbragia P, Gelisse R, Pieri B, et al. Tissue Doppler echocardiography for the diagnosis of new-onset heart failure with normal ejection fraction: influence of serum protein concentration on clinical interpretation in elderly patients. Arch Cardiovasc Dis 2008;101:343-50.
49. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991;17:1065-72.
50. Puri S, Dutka DP, Baker BL, Hughes JM, Cleland JG. Acute saline infusion reduces alveolar-capillary membrane conductance and increases airflow obstruction in patients with left ventricular dysfunction. Circulation 1999;99:1190-6. (Pubitemid 29120091)
51. Sutcliffe PD, Aaronson KD, Cody RJ, Koelling TM. Impact of serial changes in cardiac hemodynamics on exercise performance in patients with heart failure due to ischemic and nonischemic cardiomyopathy. Am J Cardiol 2003;91:164-8. (Pubitemid 36084301)
52. Agricola E, Picano E, Oppizzi M, Pisani M, Meris A, Fragasso G, et al. Assessment of stress-induced pulmonary interstitial edema by chest ultrasound during exercise echocardiography and its correlation with left ventricular function. J Am Soc Echocardiogr 2006;19:457-63.
53. Thierer J, Acosta A, Vainstein N, ultan M, Francesia A, Marino J, et al. Relation of left ventricular ejection fraction and functional capacity with metabolism and inflammation in chronic heart failure with reduced ejection fraction (from the MIMICA Study). Am J Cardiol 2010;105:977-83.
54. Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 1992;152:125-30.
55. Engelman DT, Adams DH, Byrne JG, Aranki SF, Collins JJ Jr, Couper GS, et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 1999; 118:866-73. (Pubitemid 29511069)
56. Grimm G, Haslacher H, Kampitsch T, Endler G, Marsik C, Schickbauer T, et al. Sex differences in the association between albumin and all-cause and vascular mortality. Eur J Clin Invest 2009;39: 860-5.
57. Famakin B,Weiss P, Hertzberg V, McClellanW, Presley R, Krompf K, et al. Hypoalbuminemia predicts acute stroke mortality: Paul Coverdell Georgia Stroke Registry. J Stroke Cerebrovasc Dis 2010;19: 17-22.
58. Lyons O, Whelan B, Bennett K, O'Riordan D, Silke B. Serum albumin as an outcome predictor in hospital emergency medical admissions. Eur J Intern Med 2010;21:17-20.
59. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995;47:884-90.
60. Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Tang WW, Methvin A, Smith AL, et al., for the Health ABC Study. Serum albumin concentration and heart failure risk: the Health, Aging, and Body composition Study. Am Heart J 2010;160:279-85.
61. Filippatos GS, Desai R, Ahmed MI, Mujib M, Ahmed A. Hypoalbuminemia is an independent predictor of incident heart failure in community-dwelling older adults without prevalent heart failure. Eur Heart J 2010;31(abstract suppl):169.
62. Castro GP, Verdejo PH, Vukasovic RJL, Garces E, Gonzalez I, Grupo ICARO. Predictors of hospital death and prolonged hospitalization in patients with cardiac failure in Chilean hospitals. Rev Med Chil 2006;134:1083-91. (Pubitemid 44800164)
63. Kinugasa Y, Kato M, Sugihara S, Hirai M, Kotani K, Ishida K, et al. A simple risk score to predict in-hospital death of elderly patients with acute decompensated heart failure. Hypoalbuminemia as an additional prognostic factor. Circ J 2009;73:2276-81.
64. Arques S, Pieri B, Biegle G, Roux E, Gelisse R, Jauffret B. Comparative value of B-type natriuretic peptide and serum albumin concentration in the prediction of in-hospital mortality in elderly patients admitted for acute severe heart failure. Ann Cardiol Angeiol (Paris) 2009;58:279-83.
65. Yanagisawa S, Miki K, Yasuda N, Hirai T, Suzuki N, Tanaka T. Clinical outcomes and prognostic factor for acute heart failure in nonagerians: impact of hypoalbuminemia on mortality. Int J Cardiol 2010;145: 574-6.
66. Dominguez JP, Harriague CM, Garcia-Rojas I, González G, Aparicio T, González-Reyes A. Acute heart failure in patients over 70 years of age: precipitating factors of decompensation. Rev Clin Esp 2010;210:497-504.
67. López Castro J, Almazán Ortega R, Pérez De Juan Romero M, González Juanatey JR. Mortality prognosis factors in heart failure in a cohort of North-West Spain. EPICOUR Study. Rev Clin Esp 2010; 210:438-47.
68. De Groote P, Mouquet F, Lamblin N, Dagorn J, Le Tourneau T, Hennebert O, et al. Serum uric acid is a powerful predictor of survival in patients with stable chronic heart failure receiving beta-blocker therapy. Circulation 2007;116:II-650.
69. Jackson CE, Bezlyak V, Tsorlalis IK, Dalzell JR, Myles RC, Spooner R, et al. Multimarker laboratory testing in acute decompensated heart failure (ADHF) - how much prognostic information do novel biomarkers BNP, troponin and CRP provide in addition to routine laboratory tests? Eur Heart J 2009;30(abstract suppl):711.
70. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb- Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050-3. (Pubitemid 27158249)
71. Miyamoto M, McClure DE, Schertel ER, Andrews PJ, Jones GA, Pratt JW, et al. Effects of hypoproteinemia-induced myocardial edema on left ventricular function. Am J Physiol 1998;274:H937-44.
72. Mehlhorn U, Allen SJ, Davis KL, Geissler HJ, Warters RD, Rainer de Vivie E. Increasing the colloid osmotic pressure of cardiopulmonary bypass prime and normothermic blood cardioplegia minimizes myocardial edema and prevents cardiac dysfunction. Cardiovasc Surg 1998;6:274-81. (Pubitemid 28319764)
73. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006;104:1223-31. (Pubitemid 43852956)
74. Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U, et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009;87:956-65.
75. Desai KV, Laine GA, Stewart RH, Cox CS Jr, Quick CM, Allen SJ, et al. Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 2008;294:H2428-34.
76. Dongaonkar RM, Stewart RH, Geissler HJ, Laine GA. Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. Cardiovasc Res 2010;87:331-9.
77. Pichette V, Geadah D, du Souich P. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit. Drug Metab Dispos 1999;27:81-5.
78. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002;30:2175-82. (Pubitemid 35191564)
79. Elwell RJ, Spencer AP, Eisele G. Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 2003;37:695-700. (Pubitemid 36523067)
80. Chomsky DB, Lang CC, Rayos G, Wilson JR. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. J Heart Lung Transplant 1997;16:846-53. (Pubitemid 27362685)
81. Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004;93:1254-9. (Pubitemid 38595679)
82. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122:265-72.
83. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-9. (Pubitemid 38340073)
84. Aquilani R, Opasich C, Verri M, Boschi F, Febo O, Pasini E, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003;42:1218-23.
85. Paccagnella A, Calò MA, Caenaro G, Salandin V, Jus P, Simini G, et al. Cardiac cachexia: preoperative and postoperative nutrition management. JPEN J Parenter Enteral Nutr 1994;18:409-16. (Pubitemid 24299608)
86. Aquilani R,Viglio S, Iadarola P, Opasich C, Testa A, Dioguardi FS, et al. Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure. Am J Cardiol 2008;101:104E-10E-.
87. Aquilani R, Opasich C, Gualco A, Verri M, Testa A, Pasini E, et al. Adequate protein-energy intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail 2008;10:1127-35.
88. Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol 2008;101:89E-103E.
89. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New Engl J Med 2004;350: 2247-56. (Pubitemid 38669207)
90. Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, et al., SAFE Study Investigators. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 2006;333:1044.
91. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A metaanalysis of cohort studies and controlled trials. Ann Surg 2003; 237:319-34. (Pubitemid 38176446)
92. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005;33:1681-7. (Pubitemid 41153690)
93. Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006;34: 2536-40. (Pubitemid 44413049)
94. Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, et al., SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. New Eng J Med 2007;357:874-84.
95. Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R, SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011;37:86-96.
96. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and metaanalysis. Crit Care Med 2011;39:386-91.